Search Result "relapsing-remitting multiple sclerosis."


An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14 Issue: 6 Year: 2015 Page: 804-810
Author(s): Rodica Balasa,Smaranda Maier,Septimiu Voidazan,Adina Hutanu,Zoltan Bajko,Anca Motataianu

Oral Agents in Multiple Sclerosis

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2015 Page: 15-25
Author(s): L. Lorefice,G. Fenu,J. Frau,G.C. Coghe,M.G. Marrosu,E. Cocco

Mouse Models of Multiple Sclerosis: Lost in Translation?

Journal: Current Pharmaceutical Design
Volume: 21 Issue: 1 Year: 2015 Page: 2440-2452
Author(s): David Baker, Sandra Amor

Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis

Journal: Current Drug Metabolism
Volume: 16 Issue: 8 Year: 2015 Page: 602-608
Author(s): Mahmood Rasool,Arif Malik,Abdul Manan,Shakeel Ahmed Ansari,Muhammad Asif,Mahmood Husain Qazi,Mohammad Amjad Kamal,Peter Natesan Pushparaj

Induction and Escalation Therapies in Multiple Sclerosis

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2015 Page: 26-34
Author(s): G. Fenu,L. Lorefice,F. Frau,G.C. Coghe,M.G. Marrosu,E. Cocco

Ion Channel Modulation as a Therapeutic Approach in Multiple Sclerosis

Journal: Current Medicinal Chemistry
Volume: 22 Issue: 38 Year: 2015 Page: 4366-4378
Author(s): R. Arnold,W. Huynh,M.C. Kiernan,A.V. Krishnan

The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14 Issue: 2 Year: 2015 Page: 157-167
Author(s): Wouter W. Kamphuis,Claudio Derada Troletti,Aric Reijerkerk,Ignacio A. Romero,Helga E. de Vries

Immune System Induction of Nerve Growth Factor in an Animal Model of Multiple Sclerosis: Implications in Re-Myelination and Myelin RepairATION AND MYELIN REPAIR

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14 Issue: 8 Year: 2015 Page: 1069-1078
Author(s): Crystal Acosta,Claudia Cortes,Khaled Altaweel,Heather MacPhee,Britta Hoogervorst,Harpreet Bhullar,Brain MacNeil,Mahmoud Torabi,Frank Burczynski,Michael Peter Namaka

Is β-catenin neutralization cross-involved in the mechanisms mediated by natalizumab action?

Journal: Current Molecular Medicine
Volume: 15 Issue: 10 Year: 2015 Page: 990-993
Author(s): M. Galuppo,E. Mazzon,S. Giacoppo,O. Bereshchenko,S. Bruscoli,C. Riccardi,P. Bramanti

Micro- and Nano-particulate Strategies for Antigen Specific Immune Tolerance to Treat Autoimmune Diseases

Journal: Pharmaceutical Nanotechnology
Volume: 3 Issue: 2 Year: 2015 Page: 85-100
Author(s): Naihan Chen, Kevin J. Peine, Eric M. Bachelder, Kristy M. Ainslie

Previous   Next

Go To   Results 1 - 1 of 21

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy